Lilly Price Prediction: Case for Double-Digit Upside
Eli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
Stay vigilant for fake initial coin offerings by examining whitepapers, token metrics, and regulatory disclosures to prevent losses.
17,900 articlesEli Lilly faces a pivotal year as its GLP-1 franchise powers revenue growth and new oral therapies expand addressable...
A high-stakes clash between Ray Dalio and Michael Saylor drives a renewed bitcoin price analysis as markets digest Bi...
A member of Congress with a substantial AI-focused portfolio has surged 72% this year, drawing investor attention to ...
IonQ delivers a standout Q1 and a fresh price-target outlook that signals potential triple-digit gains over the next ...
Nike delivered a quarterly beat that sent its shares higher, but investors kept a close eye on tariffs and future gui...
As AI momentum intensifies, investors re-evaluate three tech leaders. This report examines MSFT, DELL, and INTEL to a...
A revival in small-cap stocks is taking shape as three key forces converge. AI-driven demand, a steadier macro backdr...
In Q1 2026, large lenders largely stayed profitable as refinances surged and technology costs rose; however, rate vol...
SEC Commissioner Hester Peirce signals that the CLARITY Act could hit the Senate floor this summer, after House passa...
A hypothetical look at what could happen if a major AI tool faced a lawsuit over encouraging dangerous behavior. This...
As markets swing, a trio of unloved names—general mills, mattel, and mohawk—are drawing renewed attention from retire...
New Rochelle's zoning reform has sparked a housing surge, signaling a blueprint for faster development and safer lend...